Fatemeh Atyabi - Nanotechnology

Author Information

Fatemeh Atyabi is affiliated with the Department of Pharmaceutics at Tehran University of Medical Sciences and the Nanotechnology Research Centre at the Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Her research primarily focuses on the application of nanotechnology in drug delivery systems, cancer therapy, and biomedical engineering.

Research Contributions

Fatemeh Atyabi has made significant contributions to the field of nanotechnology, particularly in the development of novel nanoparticle-based drug delivery systems. Her recent work includes enhancing the delivery and cellular uptake of siRNA in breast cancer cells using trimethyl-chitosan coated gold nanoparticles, investigating the biodistribution of labeled nanoparticles in retinoblastoma models, and exploring brain-targeted delivery systems for rapamycin. She has also been involved in developing composite materials for bacterial infection treatment and addressing therapeutic obstacles in combating COVID-19.

Aliases

Fatemeh Atyabi is also known by several aliases including F Atyabi, F. Atyabi, and Fateme Atyabi.

Publication and Citation Metrics

Metric	Value
Total Citation Count	12,497
h-index	60
Paper Count	371

Publications:

Trimethyl-Chitosan Coated Gold Nanoparticles Enhance Delivery, Cellular Uptake and Gene Silencing Effect of EGFR-siRNA in Breast Cancer Cells

DOI: 10.3389/fmolb.2022.871541

Year: 2022

A Novel Nanoemulsion-Based Method to Produce Ultrasmall, Water-Dispersible Nanoparticles from Chitosan, Surface Modified with Cell-Penetrating Peptide for Oral Delivery of Proteins and Peptides [Retraction]

DOI: 10.2147/ijn.s367798

Year: 2022

Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma

DOI: 10.18502/jovr.v17i1.10171

Year: 2022

Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response

DOI: 10.1007/s11095-022-03169-2

Year: 2022

Brain targeted delivery of rapamycin using transferrin decorated nanostructured lipid carriers

DOI: 10.34172/bi.2021.23389

Year: 2022

Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel

DOI: 10.1080/10837450.2021.1875238

Year: 2021

The quest for a better fight: How can nanomaterials address the current therapeutic and diagnostic obstacles in the fight against COVID-19?

DOI: 10.1016/j.jddst.2021.102899

Year: 2021

Cellulose-Based Nanofibril Composite Materials as a New Approach to Fight Bacterial Infections

DOI: 10.3389/fbioe.2021.732461

Year: 2021

Decreased recurrence of symptoms in oral lichen planus with intralesional injection of hyaluronic acid and triamcinolone.

DOI: 10.1016/j.ijom.2021.02.028

Year: 2021

Loading Efficiency of Doxorubicin-Loaded Beta-1,3- Glucan Nanoparticles: An Artificial Neural Networks Study

DOI: 10.22034/NMRJ.2021.02.010

Year: 2021

Why are Functionalized Tips Important?

What is Light Emission in Nanotechnology?

What Role Does Nanotechnology Play in Sustainability?

What Role Can Online Resources Play?

How Can Manufacturing Defects and Environmental Noise Be Mitigated?

How Does an Ionization Gauge Work?

What are Physical Barriers in Nanotechnology?

How Can Nanotechnology Help in Detecting Metastatic Cancer?

Why is Reduced Immune Response Important in Nanotechnology?

How Do We Ensure Safety in Manufacturing and Use?

Partnered Content Networks

Relevant Topics